Santhera Pharmaceuticals (SANN), a Swiss specialty pharmaceutical company focused on medicines for rare neuromuscular diseases on Thursday announced the appointment of Orlando Oliveira as Chief Executive Officer, effective July 15, 2026.
Orlando succeeds Dario Eklund, who is stepping down after more than six and a half years as CEO. Dario would be available during a transition period to support an orderly handover.
Orlando Oliveira is a seasoned biopharma executive with more than 25 years of global experience across specialty pharmaceuticals, oncology, rare diseases, and orphan drugs.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.